menu
    • menu

    Company profile for Hopewell Therapeutics

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Hopewell Therapeutics is discovering, synthesizing, and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. They’re pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intell...
    Hopewell Therapeutics is discovering, synthesizing, and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. They’re pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry-leading companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Hopewell TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    216 West Cummings Park, Woburn, MA
    Telephone
    Telephone
    +1 781-218-3318
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.hopewell-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hopewell-therapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hopewell Therapeutics Sublicenses Lipid Nanoparticles For Cancer
    Hopewell Therapeutics Sublicenses Lipid Nanoparticles For Cancer

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250416/0/en/Hopewell-Therapeutics-Announces-Sublicense-of-Proprietary-Lipid-Nanoparticles-for-Novel-Cancer-Vaccine-to-Foxcroft-Therapeutics.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    Hopewell’s Generics Cladribine Receives Tentative Approval in US
    Hopewell’s Generics Cladribine Receives Tentative Approval in US

    04 Dec 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215547

    FDA
    04 Dec 2025
    Share Share
    Hopewell`s Generics Sapropterin 2HCl Receives Approval in US
    Hopewell`s Generics Sapropterin 2HCl Receives Approval in US

    03 Sep 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216432

    FDA
    03 Sep 2025
    Share Share
    Hopewell Lipid Nanoparticles Data At ASGCT 2024
    Hopewell Lipid Nanoparticles Data At ASGCT 2024

    07 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hopewell-therapeutics-to-present-data-highlighting-novel-tissue-targeting-lipid-nanoparticles-at-the-american-society-of-gene-and-cell-therapy-27th-annual-meeting-302137419.html

    PR NEWSWIRE
    07 May 2024
    Share Share
    Hopewell Therapeutics Announces $25 Million Seed Financing
    Hopewell Therapeutics Announces $25 Million Seed Financing

    07 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/hopewell-therapeutics-announces-25-million-seed-financing-to-advance-next-generation-lipid-nanoparticles-for-targeted-delivery-of-genomic-medicines-301844357.html

    PR NEWSWIRE
    07 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search